Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2018-04-20 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于公司股票继续停牌的公告
Regulatory Filings Classification · 100% confidence The document is a short announcement regarding the continued suspension of trading of the company's stock due to an ongoing equity restructuring plan. It does not contain financial statements, management discussion, or detailed financial data. It is a regulatory announcement about stock trading status and does not fit into categories like Annual Report, Interim Report, or Earnings Release. The document is under 5,000 characters and serves as a formal public disclosure of a trading halt, which aligns with Regulatory Filings (RNS) as a general regulatory announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2018-04-20 Chinese
关于公司股票临时停牌的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the temporary suspension (停牌) of the company's stock trading due to a planned equity restructuring that is still uncertain. It states the stock will be suspended starting April 16, 2018, for up to 10 trading days, with periodic updates during the suspension. The document does not contain financial statements, detailed financial data, or comprehensive report content. It is an official regulatory announcement about trading status and information disclosure obligations, not a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS).
2018-04-16 Chinese
中德证券有限责任公司关于公司2017年年度保荐工作报告
Regulatory Filings Classification · 95% confidence The document is titled as a "2017 Annual Sponsorship Work Report" by Zhongde Securities Co., Ltd. regarding Qidi Guhan Group Co., Ltd. It details the sponsorship work overview, including review of company disclosures, supervision of fundraising, governance oversight, and other compliance and operational checks. It also includes information about the sponsor representatives, their duties, and changes in sponsorship representatives. The document is a detailed report on the sponsor's work and supervision activities rather than a financial report or earnings release. It does not contain financial statements or earnings data. It is not an announcement of a report but the report itself. This type of document fits best under the category of Regulatory Filings (RNS) as it is a compliance and regulatory oversight report related to sponsorship work for a listed company, which does not fit other more specific categories like Annual Report or Interim Report.
2018-04-12 Chinese
中德证券有限责任公司关于公司2017年度内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding the internal control self-evaluation report of Qidi Guhan Group Co., Ltd. for the year 2017. It includes extensive discussion of internal control evaluation scope, standards for identifying internal control deficiencies, and the results of the evaluation. The document is not the internal control report itself but an independent verification or audit opinion on that report. It does not contain financial statements or quarterly/yearly financial results but focuses on internal control and governance compliance. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles, excluding full annual reports. The document length (8091 characters) and content confirm it is a substantive report rather than a brief announcement or certification letter. Therefore, the appropriate classification is AR with high confidence. FY 2017
2018-03-30 Chinese
非经营性资金占用及其他关联资金往来情况的专项说明
Audit Report / Information Classification · 95% confidence The document is a special explanation regarding non-operating fund occupation and other related party fund transactions for the year 2017 by 启迪古汉集团股份有限公司. It references audited financial statements for the year ended December 31, 2017, and includes a summary table of related party fund transactions. The document includes an auditor's review and opinion but is not the full audit report itself. It is a standalone audit-related disclosure focusing on specific accounting and regulatory compliance issues related to related party transactions and fund occupation, consistent with an Audit Report / Information filing. The document length is 1724 characters, which is short but contains substantive audit-related content rather than just an announcement or certification. Therefore, it fits best under the Audit Report / Information (AR) category. FY 2017
2018-03-30 Chinese
关于2018年度向银行申请授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's application for a credit facility (授信额度) from banks for the year 2018. It details the amount, purpose, and authorization related to the credit application. There is no financial statement, earnings data, or detailed report content. The document is a formal announcement about financing activities, specifically about credit/loan applications and related authorizations. This fits the definition of a Capital/Financing Update (CAP). The document length is short and focused on financing, not a full report or regulatory filing. Therefore, the classification is CAP with high confidence.
2018-03-30 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.